Michael Bubser

Also affiliated with Health Advances (United States), Center for Discovery

NeuroscienceBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Modulation of arousal and sleep/wake architecture by M1 PAM VU0453595 across young and aged rodents and nonhuman primates”.

Modulation of arousal and sleep/wake architecture by M1 PAM VU0453595 across young and aged rodents and nonhuman primates

Neuropsychopharmacology(2020)10.1038/s41386-020-00812-7

N/A

0DataRank · unranked

20 citations

Jason K Russell, Michael T. Nedelcovych, Michael Bubser, Anna L. Blobaum, Thomas M. Bridges +6 more

Development of VU6019650: A Potent, Highly Selective, and Systemically Active Orthosteric Antagonist of the M5 Muscarinic Acetylcholine Receptor for the Treatment of Opioid Use Disorder

Journal of Medicinal Chemistry(2022)10.1021/acs.jmedchem.2c00192

N/A

0DataRank · unranked

23 citations

Douglas L. Orsi, Rory A. Capstick, David Whomble, Jinming Li, Trever R. Carter +21 more

Discovery of VU6052254: A Novel, Potent M 1 Positive Allosteric Modulator

ACS Chemical Neuroscience(2025)10.1021/acschemneuro.5c00825

N/A

0DataRank · unranked

0 citations

Joseph D. Bungard, Christopher C. Presley, Irène Zagol-Ikapitte, Katherine J. Watson, Sichen Chang +15 more